Skip to content
Menu

Super Group (SGHC) Limited SGHC

Full chart Compare
Set alert

Price alert · SGHC

All alert types
10.25 USD -0.30 (-2.84%)

Regular-session close

10.12 -0.13 -1.27%

After hours · Nov 20, 5:40 PM ET

10.25 Day range 10.57
8.52 52-week range 15.59
YTD
-14.23%
1 year
-11.56%

Fundamental scorecard

14 of 25 checks passed on SGHC’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 2 of 5
  • Growth 5 of 5
  • Profitability 3 of 5
  • Financial health 4 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Value 2 of 5

  • Passed:P/E below its own 5-year median P/E 11.1 against a 5-year median of 15.7.
  • Passed:P/E under 20 P/E 11.1: an earnings yield of 9.0%.
  • Failed:Price to sales below its own 5-year median Price to sales 1.9 against a 5-year median of 1.1.
  • Failed:Price to book below its own 5-year median Price to book 4.8 against a 5-year median of 2.7.
  • No data:Free cash flow yield above 4% Not enough data to decide.

Growth 5 of 5

  • Passed:Revenue grew over the last year Revenue of 2.48B is +13.6% on the 12 months before.
  • Passed:Revenue grew more than 5% a year over five years +19.7% a year from FY 2020 to FY 2025.
  • Passed:Earnings per share grew over the last year EPS 0.82 against 0.44 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years +6.0% a year from FY 2020 to FY 2025.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +11.9% on the last 12 months.

Profitability 3 of 5

  • Passed:Profitable over the last year Net income of 416M over the last 12 months.
  • Failed:Profitable in each of the last five fiscal years A profit in 4 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 49.0%.
  • Passed:Net margin above its 5-year average Net margin of 16.7% against a 5-year average of 9.5%.
  • No data:Free cash flow is at least 80% of net income Not enough data to decide.

Financial health 4 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 877M against short-term liabilities of 374M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 877M against long-term liabilities of 103M.
  • Passed:Net debt under 40% of equity More cash than debt: 626M of cash against 78.0M of debt.
  • No data:Operating cash flow covers at least 20% of debt Not enough data to decide.
  • Passed:Operating profit covers interest at least 3 times Operating profit is 29.1 times the interest expense.

Dividend No data

  • No data:Pays a dividend Not enough data to decide.
  • No data:Yield above 1.5% Not enough data to decide.
  • No data:Pays out under 75% of profit Not enough data to decide.
  • No data:Covered by free cash flow Not enough data to decide.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What SGHC owns and owes, as of Sep 30, 2026

Short term and long term

Balance sheet · 1.43B of assets

Debt, equity and cash by year

Now: 548M more cash than debt

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

10.61 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A-4 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 1

Valuation

P/E 27.8×
P/S 2.7×
P/B 7.5×
P/FCF 18.5×
EV/EBITDA 15.3×
EV/Sales 2.5×
FCF Yield 5.4%

Profitability

Gross Margin 27.2%
Operating Margin 19.0%
Net Margin 9.7%
ROE 27.0%
ROIC 29.2%
ROA 17.1%

Growth (YoY)

Revenue 31.4%
Operating Income 61.4%
EPS (diluted) 95.5%
Free Cash Flow 63.3%

Financial Health

Current Ratio 1.9×
Quick Ratio 1.9×
Debt / Equity 0.1×
Net Debt / EBITDA -1.2×
Interest Coverage 38.6×

Dividends

Dividend Yield 2.6%
Payout Ratio 71.9%

Annual · latest fiscal year ends 2025-12-31